These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Comparison of iodine-123 labelled 2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane and 2 beta-carbomethoxy-3 beta-(4-iodophenyl)-N-(3-fluoropropyl)nortropane for imaging of the dopamine transporter in the living human brain. Kuikka JT, Bergström KA, Ahonen A, Hiltunen J, Haukka J, Länsimies E, Wang S, Neumeyer JL. Eur J Nucl Med; 1995 Apr; 22(4):356-60. PubMed ID: 7607268 [Abstract] [Full Text] [Related]
6. Iodine-123 labelled N-(2-fluoroethyl)-2 beta-carbomethoxy-3 beta-(4-iodophenyl)nortropane for dopamine transporter imaging in the living human brain. Kuikka JT, Akerman K, Bergström KA, Karhu J, Hiltunen J, Haukka J, Heikkinen J, Tiihonen J, Wang S, Neumeyer JL. Eur J Nucl Med; 1995 Jul; 22(7):682-6. PubMed ID: 7498231 [Abstract] [Full Text] [Related]
8. [123I] beta-CIT, a tracer for dopamine and serotonin re-uptake sites: preparation and preliminary SPECT studies in humans. Bergström KA, Kuikka JT, Ahonen A, Vanninen E. J Nucl Biol Med (1991); 1994 Dec; 38(4 Suppl 1):128-31. PubMed ID: 7632756 [Abstract] [Full Text] [Related]
9. Iodine-123 labeled nor-beta-CIT as a potential tracer for serotonin transporter imaging in the human brain with single-photon emission tomography. Hiltunen J, Akerman KK, Kuikka JT, Bergström KA, Halldin C, Nikula T, Räsänen P, Tiihonen J, Vauhkonen M, Karhu J, Kupila J, Länsimies E, Farde L. Eur J Nucl Med; 1998 Jan; 25(1):19-23. PubMed ID: 9396870 [Abstract] [Full Text] [Related]
10. Reproducibility of iodine-123-beta-CIT SPECT brain measurement of dopamine transporters. Seibyl JP, Laruelle M, van Dyck CH, Wallace E, Baldwin RM, Zoghbi S, Zea-Ponce Y, Neumeyer JL, Charney DS, Hoffer PB, Innis RB. J Nucl Med; 1996 Feb; 37(2):222-8. PubMed ID: 8667048 [Abstract] [Full Text] [Related]
12. Brain perfusion scintigraphy with 99mTc-HMPAO or 99mTc-ECD and 123I-beta-CIT single-photon emission tomography in dementia of the Alzheimer-type and diffuse Lewy body disease. Donnemiller E, Heilmann J, Wenning GK, Berger W, Decristoforo C, Moncayo R, Poewe W, Ransmayr G. Eur J Nucl Med; 1997 Mar; 24(3):320-5. PubMed ID: 9143472 [Abstract] [Full Text] [Related]
13. [18F] beta-CIT-FP is superior to [11C] beta-CIT-FP for quantitation of the dopamine transporter. Lundkvist C, Halldin C, Ginovart N, Swahn CG, Farde L. Nucl Med Biol; 1997 Oct; 24(7):621-7. PubMed ID: 9352532 [Abstract] [Full Text] [Related]
18. Human biodistribution and dosimetry of [123I]FP-CIT: a potent radioligand for imaging of dopamine transporters. Booij J, Busemann Sokole E, Stabin MG, Janssen AG, de Bruin K, van Royen EA. Eur J Nucl Med; 1998 Jan; 25(1):24-30. PubMed ID: 9396871 [Abstract] [Full Text] [Related]
19. ECT in Parkinson's disease-dopamine transporter visualised by [123I]-beta-CIT SPECT. Fall PA, Ekberg S, Granérus AK, Granérus G. J Neural Transm (Vienna); 2000 Jan; 107(8-9):997-1008. PubMed ID: 11041278 [Abstract] [Full Text] [Related]
20. [O-methyl-11C]beta-CIT-FP, a potential radioligand for quantitation of the dopamine transporter: preparation, autoradiography, metabolite studies, and positron emission tomography examinations. Lundkvist C, Halldin C, Swahn CG, Hall H, Karlsson P, Nakashima Y, Wang S, Milius RA, Neumeyer JL, Farde L. Nucl Med Biol; 1995 Oct; 22(7):905-13. PubMed ID: 8547888 [Abstract] [Full Text] [Related] Page: [Next] [New Search]